About TrueGenix
TrueGenix® is a clinically focused regenerative medicine company dedicated to advancing next-generation biologic solutions through ethically developed, proprietary regenerative technologies. Our platform is built upon a proprietary Cell-Free Bioactive Conditioned Media Complex derived from human mesenchymal stem cells and designed to support tissue repair, cellular regeneration, and functional restoration.
Rather than utilizing live stem cells, TrueGenix® therapies harness the naturally occurring bioactive signaling molecules, growth factors, cytokines, peptides, and extracellular vesicles produced during carefully controlled cell culture. This cell-free approach delivers advanced regenerative support while providing consistency, stability, and a favorable safety profile for clinical applications.
Our proprietary manufacturing and laboratory processes are designed to produce highly active conditioned media that can be incorporated into medical and aesthetic formulations intended to support healthy tissue repair and skin regeneration.
TrueGenix® develops regenerative solutions for healthcare providers, hospitals, wound care specialists, vascular surgeons, VA healthcare systems, and advanced medical spas. Our current product platform is focused on supporting:
-
Skin rejuvenation and healthy aging
-
Acne and scar improvement
-
Peripheral neuropathy support
-
Chronic diabetic wound management
-
Burn care and tissue repair
Every formulation is developed with an emphasis on scientific integrity, product consistency, and clinically relevant performance.
Our scientific research and development team is based in Irvine and Riverside, California, where experienced researchers and regenerative medicine specialists continue to advance our proprietary Cell-Free Bioactive Conditioned Media technology. Our corporate headquarters and business operations are located in Carrollton, Georgia, supporting commercialization, strategic partnerships, and customer service throughout the United States and internationally.
Built upon decades of regenerative medicine research, laboratory development, and translational science, TrueGenix® represents the convergence of advanced biotechnology and practical clinical application. Our mission is to empower physicians, hospitals, wound care providers, and healthcare professionals with innovative regenerative technologies that help improve patient outcomes while advancing the future of biologic medicine.
Leadership
William H. Gafford Jr. serves as Chief Executive Officer and Co-Founder of TrueGenix®. With more than 35 years of executive leadership experience, Bill previously served as a Georgia community bank CEO and founding director before transitioning into the healthcare industry. His background includes leadership in the durable medical equipment, diabetes management, glucose metabolism, and healthcare technology sectors, where he has worked closely with physicians, providers, and patients to commercialize innovative medical solutions.
Today, Bill leads the strategic growth of TrueGenix®, working alongside an accomplished scientific and research team to bring proprietary Cell-Free Bioactive Conditioned Media technologies to healthcare providers and patients throughout the United States and internationally. His vision is to establish TrueGenix® as a trusted leader in regenerative biologic therapies by combining rigorous science with practical clinical solutions that improve lives.